Cardiac anatomy screening: what is the best time for screening in pregnancy?

被引:31
作者
Allan, LD [1 ]
机构
[1] Kings Coll Hosp London, Harris Birthright Ctr Fetal Med Res, London SE1 9RS, England
关键词
fetal echocardiography; fetal heart; congenital heart disease; nuchal translucency;
D O I
10.1097/00001703-200304000-00009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of review To consider the ideal gestational age for cardiac evaluation during pregnancy. Recent findings Screening the heart during routine obstetric ultrasound has become well established and is increasingly successful in the initial detection of major congenital heart disease. When the option of termination of pregnancy is available, the earlier the diagnosis of any major fetal malformation is made, the better for the patient. An important group who have recently been found to be at increased risk of fetal heart malformation are those with increased nuchal translucency measurements, who are identified between 11 and 14 weeks. Thus, screening for fetal anomalies is being attempted much earlier in pregnancy, aided by advances in technology. However, some forms of cardiac malformations do not become evident until the third trimester of pregnancy; as a result, some of the late-developing lesions may go undetected during very early evaluation. Summary The ideal timing for screening is a compromise between obtaining adequate images for diagnosis in the majority of routine patients, scanning sufficiently late not to miss late-developing lesions and yet offering diagnosis as early as possible for parents to consider their options, if there are any applicable to their particular diagnosis. For low-risk patients, the best compromise appears to be at around 20 weeks of gestation. For patients at increased risk of congenital heart disease, such as those found to have substantially increased nuchal translucency or those with a family history of the disease, an initial scan to exclude major malformations should be performed by the fetal cardiology expert at 12-14 weeks, with follow-up at around 20 weeks to exclude more minor defects and those lesions which may become evident later.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 15 条
[1]   Prenatal diagnosis of congenital cardiac anomalies: A practical approach using two basic views [J].
Barboza, JM ;
Dajani, NK ;
Glenn, LG ;
Angtuaco, TL .
RADIOGRAPHICS, 2002, 22 (05) :1125-1137
[2]   Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality [J].
Bonnet, D ;
Coltri, A ;
Butera, G ;
Fermont, L ;
Le Bidois, J ;
Kachaner, J ;
Sidi, D .
CIRCULATION, 1999, 99 (07) :916-918
[3]   Early prenatal diagnosis of major congenital heart defects [J].
Carvalho, JS .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2001, 13 (02) :155-159
[4]   Improving the effectiveness of routine prenatal screening for major congenital heart defects [J].
Carvalho, JS ;
Mavrides, E ;
Shinebourne, EA ;
Campbell, S ;
Thilaganathan, B .
HEART, 2002, 88 (04) :387-391
[5]   Early prenatal diagnosis of major cardiac anomalies in a high-risk population [J].
Gabriel, CC ;
Galindo, A ;
Martínez, JM ;
Carrera, JM ;
Gutiérrez-Larraya, F ;
de la Fuente, P ;
Puerto, B ;
Borrell, A .
PRENATAL DIAGNOSIS, 2002, 22 (07) :586-593
[6]   Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries [J].
Garne, E ;
Stoll, C ;
Clementi, M .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (05) :386-391
[7]   Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype [J].
Ghi, T ;
Huggon, IC ;
Zosmer, N ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (06) :610-614
[8]   Fetal cardiac abnormalities identified prior to 14 weeks' gestation [J].
Huggon, IC ;
Ghi, T ;
Cook, AC ;
Zosmer, N ;
Allan, LD ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2002, 20 (01) :22-29
[9]   Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study [J].
Hyett, J ;
Perdu, M ;
Sharland, G ;
Snijders, R ;
Nicolaides, KH .
BRITISH MEDICAL JOURNAL, 1999, 318 (7176) :81-85
[10]   World experience of percutaneous ultrasound-guided balloon valvuloplasty in human fetuses with severe aortic valve obstruction [J].
Kohl, T ;
Sharland, G ;
Allan, LD ;
Gembruch, U ;
Chaoui, R ;
Lopes, LM ;
Zielinsky, P ;
Huhta, J ;
Silverman, NH .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (10) :1230-1233